Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of VYTORIN in Usual Practice.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2015
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Atherosclerosis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck & Co; Schering-Plough
- 04 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 24 Feb 2010 New trial record